Lumitin (conbercept) - Chengdu Kanghong Pharma
Efficacy and safety of intravitreal conbercept injection in treating macular oedema secondary to branch retinal vein occlusion: results from the BRAVE study. (PubMed, Br J Ophthalmol) - Sep 24, 2026 - P3 | "Intravitreal injections of a 0.5 mg conbercept provided improvement in visual and anatomical outcomes in BRVO-ME patients with low rates of ocular and non-ocular safety events." 
Journal • Macular Edema • Ophthalmology • Retinal Disorders • Retinal Vein Occlusion
http://www.ncbi.nlm.nih.gov/pubmed/42778337
 
Fei Yuan; Guanfang Su; Hongliang Dou; Jian Ye; Ke Yao; Li Qin; Lin Lu; Linnong Wang; Liu Yang; Luosheng Tang; Ming Zhang; Minli Huang; Pei Wang; Qi Zhang; Qiang Zheng; Qing Zhang; Qinghuai Liu; Quanhong Han; Shaowei Wang; Tiecheng Liu; Tongxin Diao; Wang Xinguo; Wenbin Wei; Xiao Ke; Xiao-Ling Liu; Xiaodong Sun; Xiaorong Li; Xiaoxin Li; Xu Han; Xuehui Shi; Xueyi Chen; Yan Shao; Yanling Wang; Yanping Song; Yongjin Zhang; Youxin Chen; Zhe-Li Liu; ZhiLi Niu; Zhujun Zhang; Zunhong Ke
 
Sep 24, 2026
 
Next